美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BlossomHill Therapeutics

25.74

-1.0800-4.03%

盤後：25.740.00000.00%19:30 EDT

成交量：71.51萬

成交額：1,847.53萬

市值：8.18億

市盈率：-10.53

高：27.55

開：26.80

低：25.41

收：26.82

52周最高：27.80

52周最低：15.25

股本：3,178.49萬

流通股本：937.50萬

量比：3.19

換手率：7.63%

股息：- -

股息率：- -

每股收益(TTM):-2.4440

每股收益(LYR):-24.8342

淨資產收益率：--

總資產收益率：--

市淨率：-5.38

市盈率(LYR):-1.04

資料載入中...

總覽公司新聞資訊公告

H.C. Wainwright 首次覆蓋 BlossomHill Therapeutics，給予「買入」評級及35美元目標價

美國研究綜述-Autodesk、Hubspot、Oracle

Blossomhill Therapeutics宣佈其宏環Omni-Egfr™抑制劑Bh-30643獲FDA快速通道資格，用於治療晚期EGFR C797S突變非小細胞肺癌

美股異動 | BlossomHill Therapeutics(BLSM.US)登陸美股市場開盤後股價小幅走低

BlossomHill Therapeutics 1.5億美元增額IPO後料平淡上市

小分子抗癌療法開發商BlossomHill(BLSM.US)IPO定價15-17美元/股擬籌資1.25億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BLSM/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BLSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","market":"US","secType":"STK","nameCN":"BlossomHill Therapeutics","latestPrice":25.74,"timestamp":1789761600000,"preClose":26.82,"halted":0,"volume":715112,"hourTrading":{"tag":"盘后","latestPrice":25.74,"preClose":25.74,"latestTime":"19:30 EDT","volume":223553,"amount":5754260.74,"timestamp":1789774206049,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04026845637583899,"floatShares":9375000,"shares":31784899,"eps":-2.444,"marketStatus":"休市中","change":-1.08,"latestTime":"09-18 16:00:00 EDT","open":26.8,"high":27.55,"low":25.405,"amount":18475261.773760002,"amplitude":0.079978,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.444,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":26.82,"preHourTrading":{"tag":"盘前","latestPrice":26.7,"preClose":26.82,"latestTime":"09:13 EDT","volume":33,"amount":889.9099769999999,"timestamp":1789737230312,"change":-0.12,"changeRate":-0.004474,"amplitude":0.021999},"postHourTrading":{"tag":"盘后","latestPrice":25.74,"preClose":25.74,"latestTime":"19:30 EDT","volume":223553,"amount":5754260.74,"timestamp":1789774206049,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.1930972043362513},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","floatShares":9375000,"roa":"--","roe":"--","lyrEps":-24.834182,"volumeRatio":3.1930972043362513,"shares":31784899,"dividePrice":0,"high":27.55,"amplitude":0.079978,"preClose":26.82,"low":25.405,"week52Low":15.25,"pbRate":"-5.38","week52High":27.8,"institutionHeld":0,"latestPrice":25.74,"eps":-2.444,"divideRate":0,"volume":715112,"delay":0,"ttmEps":-2.444,"open":26.8,"prevYearClose":16,"prevWeekClose":20.86,"prevMonthClose":18.3,"prevQuarterClose":16,"fiveDayClose":20.86,"twentyDayClose":15.8,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLSM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLSM","date":"2026-09-18","current":-10.531915,"percent":0,"low":-11.561693,"twenty":-9.371783,"median":-7.940581,"eighty":-6.940465,"high":-2.788792,"avg":-8.007458,"sd":1.613396,"marketCap":821862961},"quantilePoints":[{"date":"2026-08-07","current":-6.897356,"twenty":-6.075643,"median":-4.843074,"eighty":-3.610505,"marketCap":490298560},{"date":"2026-08-14","current":-7.048236,"twenty":-7.038752,"median":-6.897356,"eighty":-6.893907,"marketCap":501023841},{"date":"2026-08-21","current":-6.811139,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"marketCap":484169828},{"date":"2026-08-28","current":-8.535478,"twenty":-7.10945,"median":-6.974951,"eighty":-6.897356,"marketCap":606744468},{"date":"2026-09-04","current":-8.630317,"twenty":-8.140605,"median":-7.054702,"eighty":-6.899943,"marketCap":613486073},{"date":"2026-09-11","current":-9.272633,"twenty":-8.535478,"median":-7.091344,"eighty":-6.910289,"marketCap":659145126},{"date":"2026-09-18","current":-11.561693,"twenty":-9.371783,"median":-7.940581,"eighty":-6.940465,"marketCap":821862961}],"updateTime":1789906477383},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLSM\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146237583","title":"H.C. Wainwright 首次覆蓋 BlossomHill Therapeutics，給予「買入」評級及35美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1146237583","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146237583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:10","pubTimestamp":1788257420,"startTime":"0","endTime":"0","summary":"H.C. Wainwright 正式启动对 BlossomHill Therapeutics 的覆盖研究，并出具“买入”评级。此次覆盖标志着这家投资银行对 BlossomHill Therapeutics 的正式关注，评级结果也凸显出对公司战略方向及产品管线价值的认可。BlossomHill Therapeutics 专注于开发创新疗法，其研发进展及近期里程碑成果，显然已吸引卖方分析师的注意。H.C. Wainwright 的此番表态，或为市场注入新的信心，推动股价向目标价区间靠拢。整体而言，这一初次覆盖为 BlossomHill Therapeutics 的投资者提供了一个新的参考基准，也进一步巩固了其在生物科技领域中的关注度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664367078","title":"美國研究綜述-Autodesk、Hubspot、Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2664367078","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664367078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:07","pubTimestamp":1788246438,"startTime":"0","endTime":"0","summary":"美国研究综述-Autodesk、Hubspot、Oracle路透9月1日-周二，华尔街证券分析师修订了包括Autodesk、Hubspot和Oracle在内的几家美国上市公司评级及目标股价。要点* Autodesk IncADSK.O：Berenberg将目标价从335美元下调至333美元* Hubspot IncHUBS.N：TD Cowen将目标价从220美元上调至285美元* Oracle CorpORCL.N：TD Cowen将目标价从300美元下调至240美元* Salesforce IncCRM.N：TD Cowen将目标价从280美元上调至300美元* Workiva IncWK.N：贝尔德将目标价从74美元上调至95美元以下是路透周二报道的针对美国公司的研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4S44T0KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","LU1496350171.SGD","LU0390134368.USD","LU0056508442.USD","LU0432979614.USD","BK4543","LU2125910179.SGD","LU0689626769.HKD","LU0943347566.SGD","LU0048573561.USD","BK4539","LU2298064838.USD","IE0034235188.USD","LU0320765489.SGD","LU0310799852.SGD","IE00BMQBXF63.USD","LU1854103824.USD","LU2326559502.SGD","MIDD","LU0985489474.SGD","LU0175139822.USD","LU0057025933.USD","LU1803068623.USD","BLSM","LU1023059063.AUD","BK4607","LU0289961442.SGD","LU0545039389.USD","LU1121112475.USD","LU1267930813.SGD","LU2746668461.USD","BK4608","WK","LU0511384066.AUD","IE0009355771.USD","LU1720051017.SGD","LU0128525689.USD","HOOX","LU2244417387.USD","LU1721429741.USD","LU0965509283.SGD","EKG","LU2458330243.SGD","LU0256331488.USD","IE00BZ18W340.USD","LU1935042488.USD","IE00B7SZLL34.SGD","LU2756315318.SGD","TXG","GTES","LU1621768115.EUR","LU1621768206.USD","LU1670627923.USD","LU0124676726.USD","BK4144","LU0354030511.USD","HODU","DHR","ORCX","ORCZ","LU1267930573.SGD","IE00BQXX3D17.EUR","IE00B19Z9505.USD","LU1923622291.USD","LU1037948897.HKD","LU0690374615.EUR","LU1923623000.USD","SG9999013999.USD","LU0820562030.AUD","IQV","BK4588","LU0069063385.USD","LU1548497426.USD","IE00B3S45H60.SGD","LU1992135399.USD","OKE","LU0157215616.USD","IE00B19Z3B42.SGD","LU0477156797.USD","BK4566","BK4528","IE00BLSP4452.SGD","LU0878866978.SGD","LU0792757196.USD","IE00BN0W2W23.USD","LU2125909916.SGD","LU0477156953.USD","LU0081259029.USD","IE00BZ9MQY76.HKD","BK4550","LU2210149790.SGD","LU0128525929.USD","HUBS","BK4579","LU0566484027.USD","BK4535","HRTS","LU0648001328.SGD","IE00BN0W2V16.EUR","IE00B1BXHZ80.USD","LU1366192091.USD","LU0267386448.USD","LU2211817866.USD","HEAL","LU0109392836.USD","LU1506573853.SGD","OGIG","IE00B5TLWC47.USD","LU1551013425.SGD","LU1803068979.SGD","LU1815336760.USD","LU1093756325.SGD","LU0061474960.USD","LU2087625088.SGD","LU2720916845.USD","BK4598","LU1823568750.SGD","LU0426412945.USD","LU1989764664.SGD","HOOC","LU0289960550.SGD","LU1974910355.USD","LU2211814178.USD","LU2265009873.SGD","LU1854104046.USD","RGEN","LU2433249047.HKD","LU2089984988.USD","GB00BDT5M118.USD","SG9999001176.USD","LU2092937221.SGD","IE00BN8TJ469.HKD","LU0127658192.USD","LU1934455277.USD","LU2468319806.SGD","LU1670628061.USD","IE00BQXX3C00.GBP","IE00B775SV38.USD","LU0965508806.USD","LU2237957902.USD","ORCL","LU2023250504.SGD","LU1935043023.USD","LU0314104364.USD","LU2125909759.SGD","IE00BYQQ9H92.USD","LU1043141396.HKD","LU0205194284.USD","LU2210150020.SGD","IE00BD6J9T35.USD","LU0310800965.SGD","LU1878469433.USD","LU2211815571.USD","LU2360108059.USD","LU1917777945.USD","LU2404859667.USD","LU2384288077.EUR","LU1923622614.USD","LU1721429402.USD","LU0728928796.USD","IE000M9KFDE8.USD","LU1923621640.USD","LU0187121727.USD","LU1934455194.USD","LU2286300806.USD","BK4613","LU1046421795.USD","LU1261432733.SGD","FINX","IE00BJJMRZ35.SGD","LU0211328371.USD","LU1852331112.SGD","LU0980610538.SGD","BK4116","LU0426417589.USD","BK4127","LU0106261372.USD","LU0823416689.USD","LU2860962120.EUR","IE00BMPRXN33.USD","LU1496350502.SGD","LU2764262908.HKD","LU2461242641.AUD","LU0345770308.USD","BK4581","IE0002141913.USD","FMED","LU1992135472.HKD","LU0097036916.USD","LU1435385759.SGD","LU0251142724.SGD","HOYY","SGXZ57979304.SGD","LU0738911758.USD","LU0642271901.SGD","BK4527","LU0557290698.USD","LU1935042215.USD","LU0109391861.USD","SG9999011175.SGD","IE00B19Z3581.USD","LU1983260115.SGD","LU2272731600.USD","ADSK","LU1791710582.SGD","LU0122379950.USD","LU0234570918.USD","LU0861579265.USD","LU0312595415.SGD","LU0963586101.USD","LU2360106780.USD","LU0417517546.SGD","LU0648000940.SGD","LU1153585028.USD","IGV","LU0256863811.USD","LU2237957811.SGD","LU1988902786.USD","LU0130518102.USD","LU0012050646.USD","LU0690374961.EUR","BK4516","LU1989772923.USD","HOOI","LU1861558580.USD","IE00B29SXK94.USD","LU1267930730.SGD","LU1069347547.HKD","LU1559883803.SGD","LU0742534661.SGD","LU2250418816.HKD","LU0353189763.USD","IE00BJTD4V19.USD","LU0238689110.USD","LU0661504455.SGD","LU0708995401.HKD","LU0345774391.USD","LU0444971666.USD","LU0054578231.USD","CRPT","LU1815333072.USD","LU0205193047.USD","BK4505","IE00B2B36J28.USD","LU1814569148.SGD","IE00BFTCPJ56.SGD","MLPX","BK4023","LU0323239441.USD","LU0354030438.USD","IE00BKVL7J92.USD","LU2229751404.USD","LU1280957306.USD","BLCK","LU1035773651.USD","LU0130103400.USD","LU0096362180.USD","BESF","LU0006306889.USD","LU2413666699.HKD","HOOZ","LU0130102774.USD","LU1543694498.USD","BK4548","LU1951198990.SGD","LU2298321311.HKD","LU1235294995.USD","LU1003077747.HKD","LU1429558221.USD","TMED","SG9999001424.SGD","ORAC","SGXZ23171101.USD","LU0965509101.SGD","LU0052756011.USD","LU1201861165.SGD","GASZ","LU0640476718.USD","LU2764263203.CNY","SG9999004303.SGD","LU1201861249.SGD","LU1815336091.USD","LU2357305700.SGD","IE00B19Z8X17.USD","HOOG","LU0234572021.USD","LU1633808545.USD","BWA","LU0130517989.USD","LU0347712357.USD","WAT","LU0314106906.USD","BK4585","ROBN","GNMX","IE00BJT1NW94.SGD","IE0009356076.USD","LU0029864427.USD","IE00B4R5TH58.HKD","SG9999003800.SGD","LU0994945656.USD","LU0472753341.HKD","BK4124","HOOW","LU0114720955.EUR","IE0004445239.USD","LU0198837287.USD","LU2746668974.SGD","LU2125910336.SGD","LU0345770993.USD","LU1291159041.SGD","LU2125909247.SGD","LU1489326972.SGD","LU0348723411.USD","IE00BLSP4239.USD","IE00BMPRXR70.SGD","LU2125909593.SGD","IE00B5949003.HKD","LU1037948541.HKD","LU1721428933.USD","LU0882574055.USD","LU0068578508.USD","GB00B4QBRK32.GBP","LU1712237335.SGD","LU2896262040.SGD","LU0708994859.HKD","LU0672654240.SGD","LU2361045086.USD","IE00BKPKM429.USD","LU0345774631.USD","LU0528227936.USD","LU0820561909.HKD","LU0353189680.USD","IE00BLDYK493.USD","SORCLmain","LU0719512351.SGD","A","LU1935043536.SGD","BK4538","BK4121","LU1061106388.HKD","LU0106261612.USD","LU0316494557.USD","LU1621767737.EUR","LU1316542783.SGD","LU0070302665.USD","LU1267930227.SGD","LU2361044949.HKD","BK4567","LU1642822529.SGD","BK4097","LU2041044095.USD","IE00BZ18W456.USD","MLPI","IE00BZ1G4Q59.USD","LU0889565833.HKD","LU0323240290.USD","IE00BBT3K403.USD","MTD","CRM","LU2054465674.USD","HOOY","LU0210536198.USD","LU0965509010.AUD","LU1791710400.SGD","AKAL","LU1934455863.HKD","LU0820561818.USD","IE00B19Z9P08.USD","LU0310800379.SGD","BK4561","LU2063271972.USD","LU0211327993.USD","LU2756315664.SGD","ORCU","LU0949170772.SGD","IE00B64QTZ34.USD","ORCS","LU1064131342.USD","LU0011850046.USD","LU2106854487.HKD","LU1804176565.USD","FICO","HOOD","LU1093756168.USD","LU0266013472.USD","LU0342679015.USD","BK4533","LU1551013342.USD","LU0208291251.USD","LU2272731782.SGD","LU0757428866.USD","LU2543165471.USD","LU0553294199.USD","LU0957808578.USD","IE00B19Z9Z06.USD","LU1939255532.USD","BK4161","LU0444973449.USD","ARKG","LU1989772840.SGD","LU2764263039.SGD","LU2238339852.HKD","LU2458330169.SGD","IE00B894F039.SGD","BK4547","LU2264538146.SGD","LU1057294990.SGD","LU1935042991.SGD","LU0323591593.USD","LU0889566641.SGD","LU2112291526.USD","LU2108987350.USD","LU0433182093.SGD","LU2404859741.USD","LU0689472784.USD","LU1043141123.HKD","TDIV","LU0320765059.SGD","LU2361044865.SGD","IE00BJTD4N35.SGD","LU1267930490.SGD","IE00BFXG0V08.USD","PUI","GB00B4LPDJ14.GBP","LU1951200564.SGD","CRMG","AKAM","IE0002270589.USD","IE00B29SXL02.USD","LU2236285917.USD","LU2095319765.USD","IE00B19Z8W00.USD","LU2413666426.HKD","IAI","LU2247934214.USD","IE00BMPRXQ63.HKD","LU0107464264.USD","IE00BQXX3F31.USD","LU1366333091.USD","LU0476273544.USD","IE00BN0W2T93.GBP","LU0251131958.USD","HOII","LU1165135440.EUR","LU0957791311.USD","TMO","LU1989771016.USD","LU1623119135.USD","LU1059921491.USD","BK4007","BK4534","BK4554","FDIQ","RVTY","LU0082616367.USD","LU2355687059.USD","SG9999001176.SGD","LU1989764748.USD","LU1691799644.USD","BPAY","LU1621767810.EUR","BK4530","BK4504","LU0289739343.SGD","LU1983299246.USD","LU2089279066.USD","BK4532","LU1720051108.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162137187","title":"Blossomhill Therapeutics宣佈其宏環Omni-Egfr™抑制劑Bh-30643獲FDA快速通道資格，用於治療晚期EGFR C797S突變非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1162137187","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162137187?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 19:01","pubTimestamp":1787050871,"startTime":"0","endTime":"0","summary":"Blossomhill Therapeutics今日宣布，美国食品药品监督管理局已授予其候选药物Bh-30643快速通道资格。该药物是一种宏环Omni-Egfr抑制剂，专为治疗携带EGFR C797S突变的晚期非小细胞肺癌患者而设计。这一资格认定意味着Bh-30643有望加速开发和审评进程，以应对当前未被满足的医疗需求。EGFR C797S突变常被视为对现有靶向治疗产生耐药性的关键机制之一，临床挑战严峻。Blossomhill Therapeutics表示，获得快速通道资格是其推进创新疗法过程中的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640472","title":"美股異動 | BlossomHill Therapeutics(BLSM.US)登陸美股市場 開盤後股價小幅走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640472?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 00:00","pubTimestamp":1786118400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，BlossomHill Therapeutics登陆美股市场，截至发稿，该股跌超1%，报15.8美元。BlossomHill Therapeutics总部位于加州圣地亚哥，成立于2020年。该公司专注于通过识别现有治疗方法中的结构性弱点，并设计新的化合物来克服这些弱点，从而开发小分子癌症药物。公司计划于2026年第四季度与美国食品药品监督管理局举行一期临床结束会议，讨论推荐的二期临床给药方案，以及针对部分患者潜在的加速批准路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4539","LENZ","BK4139","BK4007","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657264457","title":"BlossomHill Therapeutics 1.5億美元增額IPO後料平淡上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2657264457","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657264457?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 22:24","pubTimestamp":1786112666,"startTime":"0","endTime":"0","summary":"BUZZ-BlossomHill Therapeutics 1.5亿美元增额IPO后料平淡上市8月7日-** 药物开发商BlossomHill Therapeutics在1.5亿美元增额IPO后，纳斯达克首日上市预计将持平开盘** 该股最新显示开盘价为每股16.05美元，而发行价为16美元** 总部位于加利福尼亚州圣地亚哥的BLSM公司通过规模扩大的首次公开募股，以每股16美元的价格售出约940万股 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4T44417W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNSH","BK4207","BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656536749","title":"小分子抗癌療法開發商BlossomHill(BLSM.US)IPO定價15-17美元/股 擬籌資1.25億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656536749","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656536749?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:47","pubTimestamp":1785833278,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UUP","BLSM","IPOS","UDN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}